id: late_stage_diagnosis_to_high_short_term_mortality
name: Late Stage Diagnosis of Alcohol-Associated Liver Disease â†’ High Short-term Mortality
from_node:
  node_id: late_stage_diagnosis
  node_name: Late Stage Diagnosis of Alcohol-Associated Liver Disease
to_node:
  node_id: high_short_term_mortality
  node_name: High Short-term Mortality
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Healthcare access barriers, lack of screening programs, and stigma lead
  to delayed diagnosis of alcohol-associated liver disease'
- 'Step 2: Patients often present at advanced stages including cirrhosis or alcoholic
  hepatitis when disease is already severe'
- 'Step 3: Advanced disease at diagnosis limits treatment options and reduces therapeutic
  efficacy'
- 'Step 4: Limited treatment options for severe disease manifestations result in high
  short-term mortality particularly in alcoholic hepatitis'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: N. Thakral et al. 2022. "Therapeutic Pipeline in Alcohol-Associated
    Liver Disease." *Seminars in liver disease (Print)*. https://doi.org/10.1055/s-0042-1759614
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.352502'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: alcoholic_hepatitis_presentation
  direction: strengthens
  strength: strong
  description: Alcoholic hepatitis represents a severe manifestation with particularly
    high short-term mortality when diagnosed at advanced stage
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/late_stage_diagnosis_to_high_short_term_mortality.yaml
_category: healthcare_access
